mRNA vaccine trial shows broad protection against new variant
Phase 3 data published this week show an updated mRNA vaccine provides broad protection against the emerging variant family, with efficacy above 80 pe…
1 result(s) for “Public Health”
Phase 3 data published this week show an updated mRNA vaccine provides broad protection against the emerging variant family, with efficacy above 80 pe…